Mitophagy plays a central role in mitochondrial ageing by unknown
Mitophagy plays a central role in mitochondrial ageing
Alan Diot1 • Karl Morten1 • Joanna Poulton1
Received: 29 February 2016 / Accepted: 24 May 2016 / Published online: 28 June 2016
 The Author(s) 2016. This article is published with open access at Springerlink.com
Abstract The mechanisms underlying ageing have been
discussed for decades, and advances in molecular and cell
biology of the last three decades have accelerated research
in this area. Over this period, it has become clear that
mitochondrial function, which plays a major role in many
cellular pathways from ATP production to nuclear gene
expression and epigenetics alterations, declines with age.
The emerging concepts suggest novel mechanisms,
involving mtDNA quality, mitochondrial dynamics or
mitochondrial quality control. In this review, we discuss
the impact of mitochondria in the ageing process, the role
of mitochondria in reactive oxygen species production, in
nuclear gene expression, the accumulation of mtDNA
damage and the importance of mitochondrial dynamics and
recycling. Declining mitophagy (mitochondrial quality
control) may be an important component of human ageing.
Introduction
Ageing of multi-cellular organisms is a highly complex
biological process associated with a progressive decline in
the performance of most organs, culminating in the
inability to meet environmental demands for survival
(Linnane et al. 1989). At a cellular level, it is the process
during which cells accumulate damage and changes that
affect their function. These include changes in: oxidative
stress, epigenetic status, energy availability, telomeres, loss
of stemness, mitochondrial damage and impaired cell cycle
(Wei et al. 1998; Lardenoije et al. 2015; Fyhrquist et al.
2013; Goodell and Rando 2015). These insults amount to
cellular senescence, which halts the proliferation of dam-
aged or dysfunctional cells and constrains the malignant
progression of tumour cells (Takeuchi et al. 2010).
Lopez-Otin used three simple criteria to define hall-
marks of ageing: (1) manifestation during normal ageing;
(2) experimental aggravation accelerating ageing; and (3)
experimental amelioration slowing down ageing. Accord-
ing to this study, the nine hallmarks of ageing fulfilling
these criteria are genomic instability, telomere attrition,
loss of proteostasis, deregulated nutrient sensing, altered
intercellular communication, cellular senescence, stem cell
exhaustion, epigenetic alterations and mitochondrial dys-
function (Lopez-Otin et al. 2013).
In tissue culture, senescent cells become larger follow-
ing a permanent arrest in cell cycle, due to p53 and pRB
pathways after an attempt to repair cell damage (Campisi
2005). If such non-dividing cells accumulate in vivo, they
will presumably impair the renewal and repair capacity of
the tissue. Moreover, senescence upregulates the secretion
of factors such as Interleukins (IL-6, IL-7), chemokins (IL-
8), growth factors (VEGF, HGF, SCF), receptors and
ligands (ICAM-1 and 3, EGF-R, Fas) that may vary
between tissues but affect their structure and function
(Takeuchi et al. 2010; Coppe et al. 2010). This causes
deterioration in the physiological functions of the organ-
ism, a decline in physical performance due to the decrease
in aerobic capacity and in the strength of skeletal muscles,
(Hebert et al. 2015) and eventually death. It is associated
with frailty, cardiovascular, neurodegenerative and other
age-related disease. The rising number of senescent cells is
accompanied by an increased sensitivity to apoptosis
(Tower 2015) which may explain the development of these
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degenerative disorders. Targeting cells expressing the
senescence biomarker p16Ink4a, which activates pRB to
stop cell growth, limits the accumulation of senescent cells,
hence delaying the appearance of age-related pathologies
and improving exercise tolerance (Baker et al. 2011). The
increased sensitivity of senescent cardiomyocytes to
apoptosis leads to cardiac pathologies such as hypertrophy,
fibrosis, and diminished contractility. Age-related neu-
rodegenerative disease such as Alzheimer, Parkinson and
amyotrophic lateral sclerosis are all associated with accu-
mulating aggregates of misfolded protein (reviewed in
Skovronsky et al. 2006). These can not only activate the
unfolded protein response (UPR) but also lead to calcium
dysregulation and to less energy availability due to mito-
chondria dysfunction. They may increase apoptosis, cause
neuronal loss and damage synapses.
Mitochondrial function plays a major role in many
cellular pathways such as ATP production, calcium regu-
lation, apoptosis and nucleotide synthesis. Recently,
mitochondria have been implicated in nuclear gene
expression and epigenetic alterations (Guantes et al. 2015;
Muir et al. 2016). They are thus even more likely to play a
central role in ageing than was previously believed. For
instance, work in S. cerevisiae links optimal mitochondrial
quality with longer lifespan (Higuchi et al. 2013). Mito-
chondria have been shown to be involved in telomere
length, maintenance of pluripotency, genomic instability,
cellular senescence and epigenetic alterations (Ahlqvist
et al. 2015; Correia-Melo and Passos 2015; Minocherhomji
et al. 2012; Monickaraj et al. 2012; Tyrka et al. 2015).
Mitochondrial DNA (mtDNA) damage has been widely
discussed in this context (Linnane et al. 1989). Recent
advances in understanding of mitochondrial quality control
add an important dimension to the study of ageing. Mito-
phagy is one of several processes that maintain mito-
chondrial quality, but is the only one known to turn over
whole mitochondrial genomes. While relatively unimpor-
tant in bulk turnover of all mitochondrial compo-
nents (Kim et al. 2012), it may play a critical role in the
accumulation of mtDNA damage and potentially ageing
(Payne et al. 2013; Twig et al. 2008). Furthermore,
autophagy may be an important determinant of stem cell
pluripotency (Phadwal et al. 2012) and be attenuated in
several neurodegenerative diseases (Nixon 2013).
Because of its importance, this review will therefore
focus on the mitochondrial aspects of ageing. We will
touch on a range of organisms but focus on mammalian
systems and human ageing in particular. We will discuss
how mitochondria can have such an impact, focussing on
the metabolic side, the role of mitochondria in reactive
oxygen species (ROS) production, in nuclear gene
expression and heteroplasmic mtDNA damage (where
damaged and intact mtDNA co-exist), and finally how
mitochondrial dynamics and recycling can affect the age-
ing process.
MtDNA heteroplasmy and ageing: the vicious
circle hypothesis
The causes of ageing have been discussed for decades, and
the advances in molecular and cell biology have provided
important insights into this area. It has become clear that
mitochondrial function declines with age, and the emerging
concepts suggested novel mechanisms. MtDNA was iden-
tified, characterised and shown to play a role in human
disease. Thousands of copies of mtDNA are present in
most types of cells. In normal individuals, these are iden-
tical, but in heteroplasmic mtDNA disease, normal and
mutant mtDNA co-exist in the same cells. In these dis-
eases, the dose of mutant mtDNA may increase with time,
causing progressively worsening symptoms. Low levels of
heteroplasmic mtDNA mutants may be present in symp-
tom-free maternal relatives. These findings soon suggested
an mtDNA-based theory of ageing in which an increase in
mitochondrial heteroplasmy may underlie the decline in
energy in ageing individuals. Furthermore, the uniparental
inheritance of mtDNA results in a selection asymmetry that
may explain the shorter lifespan of males than females:
mtDNA mutations that affect only males will not respond
to natural selection, imposing a male-specific disadvantage
that results from mitochondrial mutation load (Wolff and
Gemmell 2013).
However, because there is no clear maternally inherited
determinant of life-expectancy, somatic accumulation of
mtDNA damage in males could contribute to their early
death (Linnane et al. 1989). For instance, mitochondria in
human fibroblasts harbour mtDNA mutations at levels that
increase with the age of the donor, and these confer a
respiratory chain defect (Laderman et al. 1996). Further-
more, mtDNA mutations can be found in multiple different
tissue types at levels that increase with age (Simonetti et al.
1992; Bender et al. 2006; Cortopassi and Arnheim 1990;
Melov et al. 1999; Marin-Garcia et al. 2006) and may be
associated with different types of neurodegeneration such
as Alzheimer (Coskun et al. 2004) and Parkinson’s disease
(Bender et al. 2006). MtDNA deletions that are charac-
teristic of diseases due to defects in mtDNA maintenance
and accumulate in post-mitotic tissues of ageing humans
are found at increased levels in many neurodegenerative
diseases (Krishnan et al. 2008). Furthermore, these reca-
pitulate the accumulation of mtDNA rearrangements that
appear to cause senescence in fungi (Osiewacz and Her-
manns 1992). Several studies focussing on the control
region of human mtDNA showed that mutations accumu-
late in this region in muscle from 30-year olds, but not in
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brain (Calloway et al. 2000; Murdock et al. 2000). These
are de novo mutations as they are detected in grandmothers
but not in grandchildren of the same family (do Rosario
Marinho et al. 2011). It is to be noted that having a mito-
chondrial condition does not seem to worsen this effect (da
Costa et al. 2007). An array-generated single-nucleotide
polymorphism study has shown that even if overall the
heteroplasmy increases with age, some sites lose variation
while some increase it (Sondheimer et al. 2011). In the
hypervariable segment 1, especially at nucleotides 16189,
16304, and 16311, heteroplasmy seems to increase with
age (Pliss et al. 2011). This may well reflect any effect that
these polymorphisms have on mitochondrial function:
investigation of mtDNA heteroplasmy in platelets from
137 people revealed an association between increasing low
level heteroplasmy with age for known pathogenic muta-
tions and ageing phenotypes (Tranah et al. 2015). In a
mouse model of atherosclerosis, it has been shown that
mtDNA deletions associated with low COX III protein
levels appear long before atherosclerosis plaques (Tian
et al. 2016). This study shed also some light on the reason
for a decrease in mtDNA quality since it shows that OGG1,
a mitochondrial enzyme involved in mtDNA excision,
decreases with age.
If the accumulation of mtDNA mutations led to a
compensatory increase in mtDNA copy number, the dele-
tion mutants would accumulate (Elson et al. 2001). Related
ideas have been discussed widely (Linnane et al. 1989;
Melov et al. 1999; Corral-Debrinski et al. 1992; Cortopassi
et al. 1992; Osiewacz and Hermanns Osiewacz and Her-
manns 1992; Blanchard et al. 1993; Munscher et al. 1993;
Takeda et al. 1993; Tritschler and Medori 1993; Birch-
Machin et al. 1998) and led to the well-known vicious
cycle theory of ageing. This proposes that mitochondrial
dysfunction or oxidative stress caused by accumulation of
mtDNA mutants in itself damages mitochondria further. In
its simplest form, this has little supporting data (Tengan
et al. 1997), but it gathered credibility because of the sur-
prising phenotype of a mouse which was engineered to
study the effect of rapid accumulation of mtDNA muta-
tions as a result of impaired proof reading in the mito-
chondrial gamma polymerase. This Polg ‘‘mutator’’ mouse
manifests a premature ageing phenotype (Trifunovic et al.
2004). As mentioned earlier ROS levels increase with age,
especially mitochondrial ROS, and this increase in oxida-
tive stress could be responsible for de novo mtDNA
mutations that might feed the ageing process (Mikhed et al.
2015). Thus, oxidative stress/ROS produced by the mito-
chondrial electron transport chain is held to damage the
mitochondria leading exponentially to more ROS produc-
tion and mitochondrial damage. However, the predicted
exponential increase in mutation load is not apparent
(Trifunovic and Larsson 2008). Hence, a more
sophisticated version of the vicious circle hypothesis is
needed, and one that takes spatial relationships into
account provides more answers (Kirkwood and Kowald
2012). Because mitochondrial nucleoids are in close
proximity to inner mitochondrial membrane and the res-
piratory chain, the main source of cellular ROS, they are
highly susceptible to ROS-induced damage. Hence, exter-
nal oxidative stress would likely have an insignificant
effect on mtDNA damage, even when it substantially
increases protein oxidation. This would also explain why
simply manipulating general anti-oxidant concentrations
does not robustly rescue the damage (Kirkwood and
Kowald 2012). It is further supported by a tissue culture
study showing that the age-associated decrease in cell
spreading induces an increase in ROS production and an
increase in mtDNA mutations (Quan et al. 2015). Moreover
telomere length may be linked to the mtDNA content and
quality (Monickaraj et al. 2012; Tyrka et al. 2015). How
they relate to each other remains to be determined. In one
scenario, telomerase protects mitochondria from mild
oxidative stress (Ahmed et al. 2008). Other authors suggest
that p53 repression of PGC-1 promoter due to a telomere
dysfunction could be involved or that TERT affects
mtDNA repair (Monickaraj et al. 2012; Tyrka et al. 2015).
Many studies have investigated transmission of hetero-
plasmy, distinguishing between selection in the germline
and in somatic tissues with rapid turnover, such as
intestinal crypts. Low-level heteroplasmy and non-patho-
genic mutations are readily transmitted in the germline
(Sondheimer et al. 2011; Giuliani et al. 2014; Greaves et al.
2014). Pathogenic mutations tend arise in somatic cells
rather than the germline, only becoming apparent in early
adulthood. This is entirely consistent with purifying
selection during mtDNA transmission (Greaves et al.
2014). Interestingly, next-generation sequencing showed
that the mtDNA mutation rate does not seem to increase
with age (Greaves et al. 2014). This suggests that ageing
affects other processes, such as mtDNA turnover, and that
these underline the accumulation of mutant mtDNA post-
mitotic tissues. Perhaps the best evidence to support the
mitochondrial theory of ageing is the finding that passive
transmission of mtDNA mutations, generated by Polg
mutations in preceding generations, can induce a mild
ageing phenotype in the absence of an ongoing defect in
mtDNA maintenance (Ross et al. 2013).
Our recent study shows that mitophagy in skin fibrob-
lasts declines as the age of the donor increases. Moreover,
forcing cells to rely on their mitochondria to produce
energy induces mitophagy that specifically eliminates
mutant mtDNA (Diot et al. 2015). This may contribute to
the improvement of mitochondrial function and the bene-
ficial effect of exercise (Romanello and Sandri 2015) and
caloric restriction in delaying the ageing process and
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concomitant deterioration in mitochondrial function. The
increase of sirtuin 3 localised to mitochondria and involved
in mitochondrial ROS detoxification, ATP production and
network dynamics (Jacobs et al. 2008; Ahn et al. 2008;
Samant et al. 2014; Hirschey et al. 2010; Jing et al. 2013;
Papa and Germain 2014), during exercise or the activation
of mitophagy following caloric restriction would trigger
the clearing of mutant mtDNA. This should reduce the
level of heteroplasmic mutant mtDNA and improve mito-
chondrial quality and function.
Mitochondrial function, ROS production
and ageing
Declining mitochondrial activity is a well-known feature of
ageing (Hebert et al. 2015). Recent studies have shown that
mitochondrial dysfunction has a role to play in senescence
and in the ageing phenotype of the immune system. In
dendritic cells, mitochondrial membrane potential, the ATP
turnover and mitochondrial respiratory chain (MRC) cou-
pling and OXPHOS decrease with age (Chougnet et al.
2015). These results were mimicked pharmacologically in
young dendritic cells. Other studies have shown that, with
ageing, oxygen consumption and activities of complex III
and complex IV are decreased (Das and Muniyappa 2013;
Ben-Meir et al. 2015), and that this can be rescued with
coenzyme Q supplementation (Ben-Meir et al. 2015; Var-
ela-Lopez et al. 2015). This has been observed in several
tissues in human and mice model such as granulosa cells
(Ben-Meir et al. 2015), muscle (Porter et al. 2015) and
alveolar bone (Varela-Lopez et al. 2015). Impaired mito-
chondrial function may well be important in age-related
insulin resistance (Petersen et al. 2015; Goldsworthy and
Potter 2014) and in the tendency for failing hearts to use
glycolytic rather than oxidative substrates (Evans and
Clarke 2012). Further, dysfunctional mitochondria may be
a source of oxidative stress.
The free radical theory of ageing was first established in
the 1950s by Denham Harman (Harman 1956). While
excessive ROS cause oxidative stress, lower levels are
critically important in cell signalling (Schieber and Chan-
del 2014). ROS production increases with age and has been
linked to mtDNA mutations accumulation, protein oxida-
tion, shorter telomere, and increased apoptosis (Mikhed
et al. 2015; Carney et al. 1994; Salpea et al. 2013; Wang
et al. 2013). As a proof of concept, work in yeast has shown
that feeding yeast with lithocholic acid, a compound acting
on redox processes, delays ageing. It results in an
enlargement of mitochondria and an increase in the effi-
ciency of mitochondrial respiration (Burstein and Titor-
enko 2014). Similarly, reducing ROS by targeting electron
scavengers to mitochondria improves the phenotype of
sarcopenia in rats, increasing contractility, reducing protein
oxidation and increasing activity of CI, CIII, and CIV
(Javadov et al. 2015). However, it is the level of oxidative
stress rather than of ROS production that is important.
Genetic knockdown of NRMT1, a protein involved in
protein–DNA interaction, increases ROS and thus shortens
lifespan in the mouse (Bonsignore et al. 2015). When livers
from survivors were analysed, they revealed a decreased
ROS production demonstrating that it is the decreased
capacity to deal with ROS damage that causes problems in
this mouse. Again, genetic reduction in SOD1 activity also
exacerbates ageing in mice, and these display features of
altered neurotransmitter release and decreased calcium
influx (Ivannikov and Van Remmen 2015). The Polg
mutator mouse model also displays an impaired anti-oxi-
dant defence system, with reduced ergothioneine levels or
carnitine, which could result from a depletion in mito-
chondria (Clark-Matott et al. 2015). Neurotransmission in
this mouse is also altered, indicating a potential link
between ROS and neurodegeneration. Similarly, increasing
mitochondrial oxidative stress in stem cells leads to
senescence, cell cycle arrest and loss of stemness (Velarde
et al. 2015). When these mice reach old age, this results in
a thinner epidermis and delays wound closure (Velarde
et al. 2015), characteristics of an ageing phenotype. In
humans, this oxidative mechanism could be tissue specific
as a study in related women has shown that in muscle
mitochondrial function decreases with ageing, together
with a drop in MRC complex proteins and mtDNA copy
number (Hebert et al. 2015). This age-related decline in
mitochondrial function correlates with a decreased
expression with age of Sirtuin 3 (see later section) and both
can be rescued by exercise (Lanza et al. 2008).
At the cellular level, hematopoietic stem cells from aged
mice have an increased ROS levels associated with DNA
damage, apoptosis and shorter telomeres. This results in a
decreased capacity for regeneration (Porto et al. 2015).
This increase in ROS level with age, which also has a
circadian rhythm (Gong et al. 2015), could be due to a
dysregulation of mitochondrial gene expression.
However, this ROS ageing theory has been increasingly
challenged and now requires revision.
Indeed, some studies showed that although there is a
correlation between mtROS production and lifespan, the
mtROS are not directly responsible for the ageing. They
showed, however, that the mtDNA controls longevity
(Sanz et al. 2010). Similarly a knockdown of CCO-1, the
nuclear-encoded cytochrome c oxidase-1 subunit Vb/
COX4, induced a moderate alteration in the electron
transport chain, ultimately leading to an increased long-
evity (Durieux et al. 2011; Yang and Hekimi 2010). These
experiments showed that although the generation of
superoxide is increased, the overall ROS level is not.
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Moreover, the increase in superoxide appeared to be nec-
essary to improve the lifespan which would tend to indicate
the ROS could be signalling molecules instead of molec-
ular actors in ageing (Yang and Hekimi 2010). Similarly,
work on Daf-2 mutants that are defective in insulin/IGF1-
signalling, lead to the hypothesis that lifespan extension
requires a transient increase in ROS. These act as sig-
nalling molecules to increase endogenous ROS defences
and increased lifespan extending stress resistance (Zarse
et al. 2012). Indeed, constitutive Daf-2 mutants have an
increased resistance to paraquat treatment, an increased
mitochondria metabolism and an increased activity of both
SOD and catalase resulting in an overall decrease in ROS
level. This signalling pathway involves the orthologues of
AMPK, p38MAPK, NRF-2, PMK-1 and SKN-1.
In Caenorhabditis.elegans mildly inhibiting the mito-
chondrial respiratory chain, either genetically (Rea et al.
2007) or biochemically (De Haes et al. 2014) increases the
lifespan of the worm, while more severe dysfunction
shortens it (Rea et al. 2007). In tissue culture, inducing
mitochondrial dysfunction may lead to cell cycle arrest and
senescence, associated with an increase in mtDNA copy
number (Wiley et al. 2016; Zelenka et al. 2015). However,
intermittent treatment with 5 mM L-lactate (leading to ROS
production, phosphorylation of AMPK and activation of
PGC1-a) seems to improve the phenotype (Zelenka et al.
2015). The mitohormesis hypothesis (Ristow and Zarse
2010; Tapia 2006) can explain these disparate observa-
tions: a dysfunction coupled with a moderate increase in
ROS activates protective quality control pathways and
result in an overall improved mitochondria quality. How-
ever, continuous or strong MRC dysfunction leads to a
substantial accumulation of ROS, which overwhelms the
protective mechanisms. Similar ideas have been linked to
the beneficial effect of mild stresses such as exercise and
fasting (Zelenka et al. 2015; Tapia 2006).
Mitochondria–nucleus relationship in ageing
Mitochondria–nucleus crosstalk
Three decades ago the first pointers towards crosstalk
between mitochondria and nucleus became evident, the
abundance of nuclear-encoded transcripts appeared to vary
with the mtDNA content (in quantity and quality) in bud-
ding yeast (Parikh et al. 1987). The concept of the retro-
grade response emerged, in which mitochondria signal
dysfunction, thus inducing expression of nuclear genes.
One such gene is CIT2 a peroxisomal isoform of citrate
synthase, another is Rtg2p that activates the transcription
factor Rtg1p–Rtg3p (Jia et al. 1997; Sekito et al. 2000).
This retrograde response is triggered by a decrease in the
mitochondrial membrane potential (Miceli et al. 2011) and
is proportional to the extent of the mitochondrial dys-
function (Jazwinski 2005). While the precise details of the
interaction between mitochondria and nucleus differ, there
is ample evidence for such crosstalk in humans. For
instance, many defects in mtDNA maintenance are caused
by mutations in nuclear genes of the replisome (Naviaux
et al. 1999; (Kaukonen et al. 2000; Spelbrink et al. 2001),
and the mitochondrial dysfunction that results from
mtDNA depletion or damage activates responses in a large
number of nuclear genes (Hansson et al. 2004). Moreover,
the interaction between mitochondria and nuclear DNA is
important for longevity and ageing in humans because a
non-random association between mtDNA and nuclear
variability has been shown in centenarians (De Benedictis
et al. 2000).
Much recent research has been carried out to investigate
the role of epigenetics, and particularly of methylation, in
the ageing process. Changes in the methylation pattern
occur over the course of lifetime (Wang et al. 2012;
Johansson et al. 2013; McClay et al. 2014). These changes
can be either towards hypermethylation or hypomethyla-
tion (Johansson et al. 2013) with the CpG-rich promoters,
preferential sites for methylation, tending to get hyperme-
thylated and regulatory regions, poor in CpG, getting
hypomethylated (Heyn et al. 2012). A study by Horvarth
et al. has proposed the existence of an epigenetic clock
formed by 343 CpG sites. Alterations at these sites are
linked to increased risk of cancer and ageing phenotypes
(Horvath 2013). The methylation status is the result of the
effect of different factors such as sex, genetics, smoking
and environmental constraints (Monick et al. 2012; Shen-
ker et al. 2013; Shah et al. 2014).
Many studies have shown the importance of mitochon-
drial–nuclear crosstalk. In cultured cells, mitochondrial
content is central to nuclear gene expression (Guantes et al.
2015; Muir et al. 2016); DNA methylation is linked not
only to mtDNA copy number (Smiraglia et al. 2008) but
also to the mtDNA haplotype (Bellizzi et al. 2012; Kelly
et al. 2013). In addition, as most mitochondrial proteins are
nuclear encoded, they can also be regulated at the epige-
netic level; PolgA, for example, a nuclear-encoded mito-
chondrial protein involved in mtDNA replication, is
dynamically regulated throughout development with its
methylation status being negatively correlated with the
mtDNA copy number (Kelly et al. 2012). It is thus likely
that DNA epigenetics and mitochondrial function are
controlling each other via a feedback loop (Koczor et al.
2013). Other DNA modifications, such as acetylation, also
seem to be regulated by mitochondria and ATP levels
(Wellen et al. 2009).
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The sirtuins play a key role in many
of the processes that underlie ageing
Sirtuins, also known as Silent information regulator two
(Sir2) proteins, regulate important biological pathways in
eukaryotic cells and hence play a key role in many of the
processes that underlie ageing. They have a histone
deacetylase and mono-ribosyltransferase activity which is
connected to the energy of the cell by sensing NAD:NADH
ratio, NAD, NADH or nicotinamide levels. They affect
modifications of histones and other proteins to regulate
multiple cellular functions. Interest in their role in the
regulation of lifespan and the ageing process began in 2001
with the finding that Sir2, encoding the sirtuin 1 protein
(SIRT1), acts as a lifespan regulator in yeast. Sir2 over-
expression increases lifespan (Tissenbaum and Guarente
2001) with mutations causing a severe reduction in lifespan
(Kaeberlein et al. 1999). This result has been reproduced in
mice and drosophila (Kanfi et al. 2012; Whitaker et al.
2013). Whether or not SIRT1 mediates the beneficial
effects of caloric restriction on lifespan is still under debate
(Kaeberlein et al. 2004; Tsuchiya et al. 2006). In humans,
SIRT1 is involved in ageing and a positive correlation
between its levels of expression and the mitotic activity has
been established (Bai et al. 2014; Sasaki et al. 2006).
Similarly its activation in mice does improve the lifespan
of the animal (Mitchell et al. 2014).
The sirtuin family is composed of seven sirtuins with
three localised to mitochondria including sirtuin 3 (SIRT3),
which is localised to the mitochondrial matrix and has been
implicated in age-related diseases (Zeng et al. 2014; Tao
et al. 2014). This protein is involved in the regulation of
mitochondrial ROS detoxification, ATP production and
network dynamics by activation of the fusion protein
OPA1, fatty acyl oxidation, metabolism and mitochondrial
UPR (Jacobs et al. 2008; Ahn et al. 2008; Samant et al.
2014; Hirschey et al. 2010; Jing et al. 2013; Papa and
Germain 2014). SIRT3 appears to be a mediator of caloric
restriction as its expression and effect on mitochondrial
protein acetylation is increased by 24 h of fasting (Jing
et al. 2013). However, the exact role of SIRT3 in the
ageing process remains unclear. Down-regulation of SIRT3
results in several age-related diseases including cancer,
diabetes, cardiac pathologies and neurodegenerative dis-
orders. In a mouse model, knocked out for SIRT3 (SIRT3
KO) an accelerated ageing phenotype is observed, mito-
chondrial integrity is lost, and MEFs are more prone to
immortalisation (Kim et al. 2010). In this mouse model, a
proportion of SIRT3 KO mice develop spontaneous cancer
at old age. In humans, SIRT3 is found downregulated in
several cancers, such as ovarian, breast, liver and gastric
cancers (Finley et al. 2011; Zhang and Zhou 2012; Yang
et al. 2014), potentially via an increased mitochondrial
oxidative stress (Schieber and Chandel 2014; Kim et al.
2010) and associated changes in cell metabolism (Haigis
et al. 2012).
As mentioned earlier, SIRT3 is also involved in meta-
bolic disease such as diabetes. SIRT3 KO mice show an
accumulation of lipids in liver and impaired fatty acid
oxidation (Hirschey et al. 2010). They also develop a
peripheral insulin resistance with a decreased PDH activity
(Jing et al. 2013). Furthermore SIRT3 is implicated in
preventing the metabolic shift away from fatty acid oxi-
dation and towards glycolysis and in limiting the ROS
production and the activity of transcription, and translation
initiation factors involved in cardiac hypertrophy in the
failing heart (Sundaresan et al. 2009).
Finally SIRT3’s role in mitochondrial function and high
expression levels in the brain (Zeng et al. 2014; Ban et al.
2013; Sidorova-Darmos et al. 2014) make it a potential
target for therapeutics aimed at preventing neurodegener-
ative disease. SIRT3 overexpression has been shown to
protect neurons from cellular stresses such as ROS (Weir
et al. 2012; Dai et al. 2014) and mitochondrial dysfunction
and apoptosis due to SOD1 mutations (Song et al. 2013).
SIRT3 reduction of ROS-associated damage is manifestly
beneficial in mice as it slows down age-related hearing loss
during caloric restriction (Someya et al. 2010).
Caloric restriction and sirtuins
One strategy to limit the ageing effect is a calorie-restricted
diet. This was first found to increase lifespan in mice
(Sohal et al. 1994). The same study showed that age-related
oxidative damage could be prevented by caloric restriction.
These results were then confirmed in muscle from mice and
heart from rats, where caloric restriction limits mitochon-
drial-associated oxidative damage (Lass et al. 1998; Gre-
dilla et al. 2001). In yeast, caloric restriction extends
lifespan by decreasing the NADH levels leading to an
activation of Sir2 and a shift of the metabolism towards
respiration (Lin et al. 2002, 2004). Overall caloric restric-
tion seems to improve mitochondrial function, by
enhancing the transcription of ROS scavengers and pro-
teins linked to energy metabolism (Sreekumar et al. 2002).
It protects mitochondria against mitochondrial DNA dele-
tions (Cassano et al. 2004), against apoptosis by inducing
SIRT1 (Cohen et al. 2004) and induces mitochondrial
biogenesis (Lopez-Lluch et al. 2006; Civitarese et al. 2007)
to improve mitochondrial function. Hypothetically since
biogenesis is increased, degradation of dysfunctional
mitochondria might also be increased; the first clue sup-
porting this was that the expected decline in autophagy
with age could be rescued by caloric restriction (Bergamini
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et al. 2003). More interestingly, a recent study has shown a
protective effect of mitophagy on oxidative damage (Cui
et al. 2013). Kidneys from rats under a calorie restriction
diet displayed an increased mitophagy and less mitochon-
drial damage together with a decrease in a marker of
senescence.
Mitochondrial dynamics, quality control
and ageing
Mitochondrial fusion and fission and determinants
of lifespan
Studies in yeast have shown that mitochondrial dynamics
are an important determinant of lifespan (Bernhardt et al.
2015). This appears to depend on mitochondrial dynamics
rather than the organisation of the mitochondrial network
in itself (Bernhardt et al. 2015; Chen et al. 2005). In yeast,
double mutants yeast for Mgm1 and Dnm1 have a mito-
chondrial network morphology similar to that of wild-type,
their mitochondrial function is affected and their replica-
tive lifespan is decreased (Bernhardt et al. 2015). Several
other studies have linked fragmentation of the mitochon-
drial network with reduced lifespan (Braun and Wester-
mann 2011; Aerts et al. 2008; Aerts et al. 2009). On the
other hand, caloric restriction has been shown to decrease
the expression of mitochondrial fission factors Drp1 and
Fis1 and to upregulate the fusion factor Mgm1, resulting in
a more filamentous network (Goldberg et al. 2009). In Rat,
caloric restriction leads to the same effect and an increase
in cristae number has been observed (Khraiwesh et al.
2014). These results are recapitulated in mammalian sys-
tems. For instance, a study of retina of young and old mice
shows a change of mitochondrial dynamics in the retina
with age: there is a decline of FIS1 and OPA1 in the
ganglional cells and the outer plexiform layers. This con-
trasts with an increase in both OPA1 and FIS1 in the inner
segment where damage is most likely to accumulate, sug-
gesting a compensatory increase in mitochondrial turnover
in this key region (Kam and Jeffery 2015). These results
were further confirmed using electron microscopy reveal-
ing fragmented mitochondria in the retina. In a seminal
study, Chen et al. showed that mitochondrial fusion is
essential to maintain mitochondrial function in tissue cul-
ture. Loss of the mitochondrial fusion proteins OPA1 or
MFN1 and 2 led to mitochondrial fragmentation, poor cell
growth and impaired mitochondrial respiration (Chen et al.
2005). Mitochondrial fragmentation that did not signifi-
cantly affect dynamics was insufficient to do this. Simi-
larly, disrupting mitochondrial fission did not affect
mitochondrial function or cell growth. However, in another
study, inhibiting fission disrupted mitochondria segregation
and was responsible for loss of properties (Katajisto et al.
2015). These investigators observed that in stem-like cells
division is asymmetric; some cells inherit mainly ‘‘old’’
mitochondria and loose their stemness properties (self-re-
newal and pluripotency), whereas others get young mito-
chondria and stay stem-like. This indicates that a
mechanism exists to sort old and young mitochondria and
highlights the importance of mitochondrial turnover and
quality in maintaining ‘‘stemness’’.
Given that the cell uses several ways to maintain
mitochondria (Rugarli and Langer 2012), what aspect of
mitochondrial dynamics determine their propensity to age?
MtDNA mutations tend to accumulate when the
fusion/fission cycles are less frequent and there is less
mtDNA mixing. Fusion appears to be important for mixing
content of different mitochondrions (Tam et al. 2013; Chan
2012) hence keeping the network relatively homogeneous.
It needs, however, to be opposed to enough counteracting
fission events as there are numerous studies reporting that a
fission arrest or a huge increase in fusion are detrimental.
These include studies that show mitochondria hyperfila-
mentation that is apparent in brain from patients or mouse
model of AD and leads to cellular senescence (Zhang et al.
2016; Park et al. 2010).
As well as affecting the fusion and fission of mem-
branes, changes in mitochondrial dynamics also drive
mitochondrial turnover. Hence mitochondrial hyperfusion
can slow down axonal transport in neurons (Takihara et al.
2015) or inhibit mitophagy and worsen the quality of the
pool of mitochondria (Park et al. 2010), which can lead to
sarcopenia in muscle (Leduc-Gaudet et al. 2015). Increas-
ing the expression of mitophagy protein PARKIN appears
to improve mitochondrial turnover and reduce ageing in
flies (Rana et al. 2013). Ferree et al. have shown that the
turnover is also important to keep mitochondria ‘‘young’’
(Ferree et al. 2013). Recently resveratrol, which has a
positive effect on lifespan, was shown to activate the
Pink1/Parkin pathway by upregulating the glutathione
levels in cells (Das et al. 2014). Finally, it is to be noted
that lifelong caloric restriction results in a change in
mitochondrial size and mass as well as ultrastructure
(Khraiwesh et al. 2014). This also could be explained by a
higher turnover rate and an overall improved mitochondrial
quality.
Effects of mitochondrial stress on lifespan can be
rescued by UPRmt activation
UPRmt is a stress response triggered by the accumulation
of unfolded protein in mitochondria. It promotes expres-
sion of mitochondrial chaperones (Durieux et al. 2011),
limits protein import (Wrobel et al. 2015) and reduces
mitochondrial translation (Haynes et al. 2013). The
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accumulation of unfolded proteins in mitochondria has
been shown to induce nuclear genes encoding mitochon-
drial stress proteins such as Cpn60 and Cpn10 (Zhao et al.
2002). This response was shown to be transient and to
correlate with the level of aggregates and is regulated by
CHOP and C/EPBb. Some factors have been involved in
UPRmt, such as HAF-1, a matrix protein exporter to export
unfolded peptides (Haynes et al. 2010). Another mito-
chondrial stress sensor is the transcription factor, ATFS-1;
in control conditions, it is imported in the mitochondria and
degraded. When mitochondria are stressed, the import is
less efficient and a fraction of ATFS-1 accumulates in the
cytosol, allowing it to be imported in the nucleus, where it
triggers transcription of the UPRmt genes (Nargund et al.
2012). It has been recently shown to bind to OXPHOS
genes promoter. This limits the amount of transcripts
during UPRmt and promotes the OXPHOS complex
assembly and function (Nargund et al. 2015). Recently,
CLK-1, a monooxygenase known to be mitochondrial and
having a role in respiration and longevity, has been shown
to translocate to the nucleus. This nuclear form of CLK-1
mediates a retrograde signalling pathway that responds to
mitochondrial ROS. It regulates both mitochondrial ROS
and UPRmt, and this signalling is conserved from worms to
humans (Monaghan et al. 2015). The unfolded protein
degradation into peptides involves the proteases CLPxP
(Haynes et al. 2010) and Lon (Bezawork-Geleta et al.
2015). Lon appears to clear misfolded and not aggregated
proteins (Bezawork-Geleta et al. 2015).
This stress response has been related to ageing and
lifespan as, as stated earlier, a knockdown of CCO-1 in
C.elegans moderately affects the ETC and increases
longevity in an UPRmt-dependent way (Durieux et al.
2011). Work in fungi has also shed light on the involve-
ment of UPRmt in longevity as an overexpression of the
Lon protease in Podospora anserine leads to an increase in
ATP-dependent serine protease activity. These fungi have
less carbonaylated and carboxymethylated proteins and
less H2O2 secreted resulting in an increase in lifespan and
healthspan (Luce and Osiewacz 2009). Similarly mice
knocked out for Surf1 (Surfeit locus protein 1, helps in the
initial assembly of 13 subunits of the cytochrome c oxi-
dase) are viable, displaying a decrease of more than 50 %
in COX activity and have a longer lifespan. They appeared
to have the same amount of ROS, membrane potential,
ATP production and respiration in heart and muscle than
controls. However, these mice have a mitochondrial energy
metabolism decrease, which is combined to an increase in
mitochondrial biogenesis markers, Nrf2 pathway and
UPRmt. This indicates that mitochondrial dysfunction can
lead to the induction of the mitochondrial stress pathway to
confer protective effects (Pulliam et al. 2014). However,
some work in C.elegans has recently challenged this
relation between UPRmt and lifespan. There was no cor-
relation between lifespan (positively or negatively) and
UPRmt in an RNAi screen. Neither knockdown nor sta-
bilisation of ATFS-1 affected the lifespan of the worms
(Bennett et al. 2014).
Mitophagy declines during ageing: from humans
through to fungi
There is accumulating evidence that genetically increasing
autophagy delays ageing in flies (Ulgherait et al. 2014),
worms (Schiavi et al. 2015) and mice (Wu et al. 2013).
Given that mitochondria are implicated in ageing, the
increase in mitophagy that accompanies activation of
autophagy could underlie this. Indeed, the importance of
mitophagy in lifespan has been confirmed in drosophila
where overexpression of Parkin leads to increased lifespan
and decreased protein aggregation (Rana et al. 2013). Flies
have decreased dMFN levels, fragmented mitochondria
and show increased mitochondrial function. Parkin over-
expression also extends neuron longevity and reduces
protein aggregation in the brain. In C.elegans, mitophagy
has been shown to be required for longevity under condi-
tions of low-insulin/IGF-1 signalling or impaired mito-
chondrial function (Palikaras et al. 2015). Similarly feeding
worms with lithium, an inducer of macroautophagy,
improved lifespan and mitochondrial function (Tam et al.
2014). This group produced a mathematical model sug-
gesting that lifespan can be extended by a combination of
rapid mitochondrial fission, fusion and mitophagy to
maintain mitochondrial function. This is also supported by
the finding that mitophagy can be induced in response to
frataxin depletion and that this increases lifespan of the
worm (Schiavi et al. 2015).
The same kind of work has been carried out in the mouse
where old mice have been fed with trehalose, a mitophagy
inducer. These mice displayed an improvement of the levels
of the mitochondrial quality controls mediators, especially
PARKIN, BNIP3, SIRT3 and PGC1a, when compared to
controls mice (LaRocca et al. 2014). Their artery walls do
not stiffen and these results were reproduced ex vivo on
arterial rings. As reported earlier, caloric restriction diet
leads to increased mitophagy and decrease in both mito-
chondrial damage and markers of senescence in rats (Cui
et al. 2013). The PolG mutator mouse, which accumulates
mtDNA mutations and undergoes premature ageing and
sarcopenia, displays evidence of increased autophagy with
an increased expression of PGC1-a and mitochondrial
fragmentation when compared to age-matched control
(Joseph et al. 2013). In contrast to the other models dis-
cussed above, here the increased autophagy is insufficient to
enhance mitochondrial quality in the presence of massive
mtDNA damage (Li-Harms et al. 2015). Interestingly in
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humans, exercise, which has been shown to improve ageing
phenotype, induces an increase in levels of protein involved
in mitochondria biogenesis and mitochondrial dynamics
(Konopka et al. 2014).
Hence, decreased or dysregulated mitophagy likely
contributes to the decline in mitochondrial quality and
function that leads to the ageing phenotype. A recent study
has shown that in mouse and human, mitophagy is
impaired during ageing in muscle satellite cells (Garcia-
Prat et al. 2016). These are muscle-specific stem cells,
hence characterised by self-renewal and long life span,
potentially requiring mitophagy more than other cell types
(Phadwal et al. 2013). This decrease of mitophagy could be
due to an inflammation process as IL-10 null mice display a
better ageing phenotype than the control weight mice (Ko
et al. 2016).
Interestingly when mitophagy is impaired, mitochondria
send a retrograde signal through SKN-1, a transcription
factor that regulates both mitophagy and mitobiogenesis
(Palikaras et al. 2015). This mitochondria–nuclear cross-
talk important for mitochondria health and involving
mitophagy has also been highlighted in a nucleotide exci-
sion DNA repair disorder leading to neurodegeneration
(xeroderma pigmentosum group A). This disorder is char-
acterised by impaired mitophagy due to excessive PINK1
cleavage (Fang et al. 2014). This excessive processing
Fig. 1 Mitochondria quality
control improves the ageing
phenotype
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appears to be due to both an activation of PARP1 and an
attenuation of the NAD(?)-SIRT1-PGC1a pathway.
As one would expect, coordination between biogenesis
and recycling is needed to keep the pool of mitochondria
healthy. The decline in mitophagy with ageing (Diot et al.
2015) thus disadvantages both the turnover of dysfunc-
tional mitochondria and the production of fresh mito-
chondria, leading to a decreased life- and healthspan.
Finally, it is important to state that UPRmt and mito-
phagy are not working independently. Notably when
unfolded proteins were expressed in the mitochondrial
matrix, PINK1 accumulated on mitochondria able to
maintain their membrane potential (Jin and Youle 2013).
This resulted in a Parkin-dependant mitophagy. CLPxP is
not needed for this response but a knockdown of LonP
protease increases the accumulation of PINK1, which is not
due to a decrease in membrane potential. In drosophila, a
mild muscle mitochondrial distress preserved the mito-
chondria function as well as the muscle function and
architecture and resulted in a prolonged lifespan (Owusu-
Ansah et al. 2013). This beneficial result was abolished by
an increase in anti-oxidant. Two pathways were identified;
one through the UPRmt and the other one due to insulin
signalling antagonisation which facilitates mitophagy
(Owusu-Ansah et al. 2013). Forced expression of UPRmt
genes, such as Hsp60, or overexpression of ImpL2 alone
was sufficient to increase lifespan. The latter induced an
increase in lysosome biogenesis and an increase in mito-
phagy was observed, manifest as mitochondria engulfed by
autophagosomes.
Conclusions
In this review, we have seen that mitochondria play a role
in ageing at different levels (Fig. 1). First, the MRC as an
important source of ROS that increases as mitochondrial
quality declines. ROS production is indeed an important
feature of the ageing process, whether it induces oxidative
damage to proteins, lipids and DNA or acts as a signalling
molecule.
Second, through their relationship with the nucleus,
mitochondria affect nuclear gene expression. We now
know that nuclear–mitochondria crosstalk is not only in the
nucleus-to-mitochondria direction, via production and
import of the vast majority of the proteins necessary to
build a mitochondrion and regulation by sirtuins. The ret-
rograde response where mitochondria content and activity
regulate nuclear gene expression is also critically important
(Guantes et al. 2015, 2016). Overall the mitochondria
content and quality appear to be important features of the
ageing process. This is highlighted by the importance of
heteroplasmy for damaged mtDNAs, presumably due to a
decreased efficiency in energy production leading not only
to more ROS being produced but also to an effect on
telomere as it has recently been suggested.
These observations convince us that mitochondria
quality control has a very (maybe the most) important part
to play in the ageing process. By modulating mitophagy,
it may be possible to improve mitochondrial quality, limit
mtDNA damage, regulate ROS production to what is
necessary for signalling and keep the nuclear gene
expression to the pattern and levels of healthy young
cells.
UPRmt is one of these quality control pathways
although its role in longevity has been recently challenged.
Stimulating mitochondrial dynamics to keep a homogenous
functional mitochondrial network is another strategy that
might prolong the ‘‘young’’ state of cells. Mitophagy
coupled to mitobiogenesis stands out, however, as the most
promising, unambiguous and potent way to keep unaltered
mitochondria and thus ‘‘young’’ cells. Learning how to
stimulate mitophagy/mitobiogenesis should represent an
important research axis in therapeutics towards ageing-re-
lated disease.
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